US regulators OK ‘female Viagra’

Rappler.com

This is AI generated summarization, which may have errors. For context, always refer to the full article.

US regulators OK ‘female Viagra’

US regulators Tuesday, August 18, approved the first “female Viagra,” a drug known as Addyi that works on the brain to boost younger women’s libido if they have lost interest in sex. Made by North Carolina-based Sprout Pharmaceuticals, Addyi, also known as flibanserin, received the nod from the US Food and Drug Administration, on the condition that extra care is taken to ensure women do not take it with alcohol due to the risk of serious side effects. The FDA approved Addyi specifically for a condition known as “acquired, generalized hypoactive sexual desire disorder (HSDD),” or sudden and severe loss of libido. The disorder can develop in women who previously were sexually active, causing distress and relationship problems, “and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.” 

Read the full story on Rappler.

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!